CRAIG SCHULTZ: Open Payments
NPI 1619911559 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,238 in 56 payments from 13 companies in 2025. Trend: 2023 $1,662 · 2024 $1,678 · 2025 $1,238
Food & beverage: $1,139Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $478 |
| Janssen Biotech, Inc. | 13 | $282 |
| Lilly USA, LLC | 11 | $136 |
| GENZYME CORPORATION | 1 | $90 |
| UCB, Inc. | 2 | $53 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
| LEO Pharma Inc. | 1 | $29 |
| PFIZER INC. | 1 | $27 |
| Organon LLC | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
Products named: SKYRIZI, TREMFYA, TALTZ, DUPIXENT, RINVOQ, Bimzelx, ANZUPGO, CIBINQO.
Industry payments across OR — which companies pay providers there.
